Fine Foods weak on the stock market on CEO change. Akros does not change its strategy

Fine Foods Pharmaceuticals reduces loss in 2023 Dividend of

(Telestock) – Weak session at Piazza Affari, even if with limited volumesfor the title Fine Foods & Pharmaceuticalsa company listed on Euronext STAR Milan and active in the development and production on behalf of third parties of solid oral forms intended for the pharmaceutical and nutraceutical industries.

Yesterday evening the company announced the resignation of the CEO Giorgio Ferraris. He will be replaced by Pietro Oriani, currently CFO of Intercos.

We do not expect the change to impact the company strategywhich has been set in recent years and which is showing its positive effects both in terms of revenue growth and profitability”, say analysts at Banca Akros.

Takes a step back from the previous closing price Fine Foods & Pharmaceuticals NTM, settling at 8.64 euroswith a 0.92% drop. Expected for the rest of the session an extension of the bearish phase with support area seen at 8.6 and then at 8.56. Resistance at 8.72.

tlb-finance